Comment from Jitendra Pund
AnonymousSupportIndividual
Summary: Jitendra Pund provides specific technical recommendations for the Phase I investigation of Out-of-Specification (OOS) test results in pharmaceutical production. The commenter suggests specific protocols for evaluating contamination, systematic hypothesis testing, the use of expired solutions for investigation, and the requirements for retesting when laboratory errors are identified.
Dear sir/ Madam,
IDENTIFYING AND ASSESSING OOS TEST RESULTS — PHASE I
1. Contamination related possible causes shall be evaluated by considering work bench verification and possibility of mix-up of glassware and interview of nearby analyst shall be taken to ensure workplace environment free from any contaminant.
2. All potential hypotheses related to the root cause of an Out-of-Specification (OOS) result—such as dilution errors, instrument malfunctions, or procedural deviations—must undergo systematic evaluation and be verified through focused testing and analytical review to confirm or eliminate their impact.
3. Use of an expired solution may be permitted during investigational or hypothesis-driven testing, provided there is a scientifically valid justification and the intent is to identify a potential assignable cause for the Out-of-Specification (OOS) result.
4. If a laboratory error is conclusively identified and scientifically validated as the probable cause of an Out-of-Specification (OOS) result during Phase-I investigation, a retest shall be performed by the original analyst. This retest must be conducted in triplicate using the same original sample that produced the initial OOS result, ensuring the previously identified error is fully corrected and excluded from the procedure.
Regards
Jitendra Pund